Jens M Kelm1, Martin Fussenegger
1Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Hoenggerberg, HPT D74, CH-8093 Zurich, Switzerland.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Scaffold-free microtissues, created from reaggregated cells, offer advanced applications in regenerative medicine. This technology enhances therapeutic transgene expression and improves drug discovery through tissue-like assay environments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: